Prescribed by oncologists for adults with: 🔹 Advanced Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer (first-line treatment or after cytokine therapy). 🔹 Advanced Soft Tissue Sarcoma (STS): For patients who have received prior chemotherapy (excluding adipocytic sarcoma and GIST).

Dosage and administration

Sales Unit: Bottle containing 28 film-coated tablets (200 mg strength). ⚠️ APPLICATION INSTRUCTIONS: How to Take: Take on an empty stomach (at least 1 hour before or 2 hours after a meal). Food significantly increases absorption, which can lead to toxicity. Method: Swallow tablets whole with water. Do not crush or chew. Standard Dose: Typically 800 mg (four 200 mg tablets) once daily. Follow your doctor's instructions for dose reduction if needed. ✋ Missed Dose: Do not take if less than 12 hours remain until the next scheduled dose.

⛔ Pregnancy & Breastfeeding: Contraindicated. Can cause fetal harm. Effective contraception is mandatory. Severe hepatic (liver) or renal (kidney) impairment. Children (under 18 years). Hypersensitivity to Pazopanib. Avoid grapefruit and grapefruit juice during treatment.

Regular monitoring of blood pressure and liver function is required. Potential side effects: 📉 Cardiovascular: Hypertension (high blood pressure). 🤢 Gastrointestinal: Diarrhea, nausea, vomiting, loss of appetite. 💅 Physical: Hair color changes (depigmentation/whitening), skin rash. 🩸 Liver: Elevated liver enzymes (hepatotoxicity). 🥱 General: Fatigue and weakness.

Pazorest — Pazopanib 200 mg, 28 product-page.units_short, Everest

100% original product

Active ingredient

Pazopanib

Manufacturer

Everest

Dosage 200 mg

Dosage form Tablets

Tablets per pack 28

Pazorest Tablets — Pazopanib 200 mg (28 Tabs) Everest

Name: Pazorest
Brand: Everest
SKU: PROD-196
Price: 30067 UAH
Availability: InStock

30067₴ ~~32437₴~~ -7%

Pazorest 200 mg (Pazopanib) is a potent multi-kinase inhibitor and a generic equivalent to Votrient. It works by interfering with the growth of cancer cells and cutting off their blood supply.

Manufacturer: Everest Pharmaceuticals (Bangladesh). Pazopanib targets multiple receptors (VEGFR, PDGFR, c-KIT) responsible for tumor angiogenesis and proliferation.

Key Features:

✅ Anti-Angiogenesis: Blocks the formation of new blood vessels that tumors need to grow.
✅ Broad Efficacy: Proven effective in treating advanced kidney cancer and soft tissue sarcomas.
✅ Flexible Dosing: The 200 mg tablet allows for precise dose adjustments to manage side effects.

Prescribed by oncologists for adults with:

🔹 Advanced Renal Cell Carcinoma (RCC): For patients with advanced kidney cancer (first-line treatment or after cytokine therapy).
🔹 Advanced Soft Tissue Sarcoma (STS): For patients who have received prior chemotherapy (excluding adipocytic sarcoma and GIST).

Sales Unit: Bottle containing 28 film-coated tablets (200 mg strength).

⚠️ APPLICATION INSTRUCTIONS:

How to Take: Take on an empty stomach (at least 1 hour before or 2 hours after a meal). Food significantly increases absorption, which can lead to toxicity.
Method: Swallow tablets whole with water. Do not crush or chew.
Standard Dose: Typically 800 mg (four 200 mg tablets) once daily. Follow your doctor's instructions for dose reduction if needed.
✋ Missed Dose: Do not take if less than 12 hours remain until the next scheduled dose.

⛔ Pregnancy & Breastfeeding: Contraindicated. Can cause fetal harm. Effective contraception is mandatory.
Severe hepatic (liver) or renal (kidney) impairment.
Children (under 18 years).
Hypersensitivity to Pazopanib.
Avoid grapefruit and grapefruit juice during treatment.